1. Home
  2. EXLS vs HALO Comparison

EXLS vs HALO Comparison

Compare EXLS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ExlService Holdings Inc.

EXLS

ExlService Holdings Inc.

HOLD

Current Price

$32.79

Market Cap

6.6B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$76.65

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXLS
HALO
Founded
1999
1998
Country
United States
United States
Employees
N/A
350
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
8.8B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
EXLS
HALO
Price
$32.79
$76.65
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$53.00
$76.42
AVG Volume (30 Days)
1.2M
1.9M
Earning Date
02-24-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
29.94
56.68
EPS
1.48
4.74
Revenue
$2,026,490,000.00
$1,242,852,000.00
Revenue This Year
$15.32
$34.54
Revenue Next Year
$11.37
$26.28
P/E Ratio
$26.87
$15.72
Revenue Growth
14.43
31.19
52 Week Low
$37.30
$47.50
52 Week High
$52.43
$79.50

Technical Indicators

Market Signals
Indicator
EXLS
HALO
Relative Strength Index (RSI) 20.36 66.20
Support Level $38.24 $71.23
Resistance Level $39.99 $74.48
Average True Range (ATR) 1.48 2.43
MACD -0.80 0.31
Stochastic Oscillator 1.58 93.83

Price Performance

Historical Comparison
EXLS
HALO

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: